Purple Biotech Ltd (TLV:PPBT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.300
+0.100 (8.33%)
At close: Dec 4, 2025
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 24.16 million as of December 5, 2025. Its market cap has increased by 12.75% in one year.
Market Cap
24.16M
Enterprise Value
-9.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 24.16M, an increase of 35.17%. That is a compound annual growth rate of 2.46%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 100.49B |
| Danel (Adir Yeoshua) | 2.70B |
| Kamada | 1.32B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 1.01B |
| Ilex Medical | 718.16M |
| Novolog (Pharm-Up 1966) | 653.92M |